Metrics
Publication
92
Open Access
5
UN Sustainable Development Goals
Education
2012 - 2017
2012 - 2017Doctorate
Istanbul University, Health Sciences Institute, Eczacılık Fakültesi Bölümü, Turkey
2010 - 2011
2010 - 2011Postgraduate
Istanbul University, Health Sciences Institute, Eczacılık Fakültesi Bölümü, Turkey
1998 - 2002
1998 - 2002Undergraduate
Istanbul University, Faculty of Pharmacy , Turkey
Dissertations
2017
2017Doctorate
Scale-Up'a Uygun Nanoemülsiyon Formülasyonunun QbD ile Tasarımı ve Yapay Sinir Ağları ile Optimizasyonu
Istanbul University, Faculty of Pharmacy , Farmasötik Teknoloji Abd
2011
2011Postgraduate
Nöro-Bulanık Mantık Yardımı ile Alfuzosin HCl İçeren Tablet Formülasyonlarının Tasarım Çalışması
Istanbul University, Eczacılık Fakültesi Eczacılık Teknolojisi, Farmasötik Teknoloji
Foreign Languages
B1 Intermediate
B1 IntermediateFrench
C1 Advanced
C1 AdvancedEnglish
Certificates, Courses and Trainings
2022
2022Enneagram - İnsan Tanıma Sanatı
Personal Evolution
İstanbul Maden ve Metaller İhracatçı Birlikleri
2022
2022Güven İnşası ve Stres Yönetimi
Personal Evolution
İstanbul Maden ve Metaller İhracatçı Birlikleri
2022
2022DİJİTAL LİDERLİK VE TEKNOLOJİK YETKİNLİKLER
Personal Evolution
İstanbul Maden ve Metaller İhracatçı Birlikleri
2022
2022Hitabet
Personal Evolution
İstanbul Maden ve Metaller İhracatçı Birlikleri
2021
2021İnsansız Hava Aracı 1 (İHA 1) Ticari Pilotu
Other
İstanbul Üniversitesi Cerrahpaşa
2019
2019Eğiticinin Eğitimi
Education Management and Planning
İstanbul Üniversitesi
2015
2015Agilent Technologies 1260 Series-DAD Hardware ve Chemstation B.04.03-SP2 Software
Vocational Training
SEM
2015
2015İyi Klinik Uygulamalar ve Temel Klinik Araştırma Eğitimi
Vocational Training
İ.Ü. Klinik Araştırmalar Mükemmeliyet Uygulama ve Araştırma Merkezi
2015
2015İş Hukuku, İSG Kavramı, Fiziksel Etkenler, Ekranlı Araçlarla Çalışma, Elektrik ile Yapılan Çalışmalarda İş Güvenliği, Kişisel Koruyucu Donanımlar, Sağlık ve Güvenlik İşaretleri, Güvenlik Kültürü, Sık Rastlanan İş Kazaları ve Korunma Yöntemleri, Meslek Hastalıkları, Kimyasal Etkenler, Yangın, Patlama, Parlama, Kimyasallardan Korunma, Yangından Korunma
Occupational Health and Safety
İstanbul Üniversitesi Sürekli Eğitim Uygulama ve Araştırma Merkezi
2015
2015MHRA GMP Veri Bütünlüğü ve Tanımlar Yönetmeliği
Vocational Training
Conval Group
2015
2015İç Denetim
Quality Management
İstanbul Üniversitesi İlaç Araştırma ve Uygulama Merkezi
2015
2015Klinik araştırmalarda Etik Yaklaşım Kursu
Vocational Training
İstanbul Medipol Üniversitesi
2015
2015İyi Laboratuvar Uygulamaları
Vocational Training
İstanbul Üniversitesi
2015
2015Temel İyi Klinik Uygulamalar Araştırmacı Eğitimi
Vocational Training
Kocaeli Üniversitesi Klinik ve Deneysel Araştırmalar Uygulama ve Araştırma Merkezi
2013
2013Deney Hayvanları Kullanım Kursu
Vocational Training
İstanbul Üniversitesi
2013
2013Mükemmelist Arge ve İnovasyon
R&D Management
İstanbul İl Özel İdaresi
2012
2012AB Proje Yönetimi
Project Management
European Certification and Qualification Assosiation
2010
2010Viskozimetre, Reoloji Konuları ve Cihazları, Yeni Texture ve Toz Akış Cihazları Tanıtımları
Vocational Training
SEM Endüstri Cihazları A.Ş.
2009
2009Granulation, Tabletting and Capsule Technology
Vocational Training
CfPA The Center for Professional Advancement
2008
2008DSC Cihazı Giriş, Uygulama ve Software Eğitimi
Vocational Training
Likrom Analitik Çözümler Paz. San. ve Tic. Ltd. Şti.
2008
2008Formulation and Process Development and Troublesooting -For Oral Solid Dosage Forms-
Vocational Training
Academia Life Sciences Center
2008
2008Ürün Güvenliği (Farmakovijilans)
Vocational Training
Sanovel
2007
2007Mastersizer 2000 Particle Size Analyzer
Vocational Training
Atomika Teknik
2007
2007HR83 Nem Tayin Cihazı
Vocational Training
SEM Mettler Toledo
2007
2007RE40D Refractometer ve DE40 Densitymeter Cihazı
Vocational Training
SEM Mettler Toledo
2007
2007Agilent Technologies 8453 UV/Dissolution Cihazı Kullanım ve Software
Vocational Training
SEM
2007
2007Agilent 1100/1200 HPLC Cihazı Hardware
Vocational Training
SEM Laboratuvar Cihazları Pazarlama San. ve Tic. Ltd. Şti.
2007
2007Ekiple Hedefe Odaklanmak
Personal Evolution
Sinerji Eğitim Danışmanlık
2007
2007Empower Software Genel Kullanıcı Eğitimi
Vocational Training
Likrom Analitik çözümler Paz. San. ve Tic. Ltd. Şti.
2007
2007Acquity UPLC Genel Kullanıcı Eğitimi
Vocational Training
Likrom Analitik Çözümler Paz. San. ve Tic. Ltd. Şti.
2006
2006Sterilizatör Validasyonları
Vocational Training
I.C.C.E. Istanbul Validation and Training Danışmanlık ve Ticaret Ltd. Şti.
2006
2006Steril Üretimi Anlamak
Vocational Training
I.C.C.E. Istanbul Validation and Training Danışmanlık ve Ticaret Ltd. Şti.
2005
2005İyi Laboratuvar Uygulamaları (GLP)
Quality Management
International Cleanroom Control Engineering
2004
2004Değişiklik Kontrol Yönetimi
Quality Management
International Cleanroom Control Engineering
Research Areas
Health Sciences
Pharmacology and Therapeutics
Pharmaceutics Technology
Pharmaceutical Technology
Biopharmaceutical and Pharmacokinetics
Academic Positions
2021 - Present
2021 - PresentAssistant Professor
Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology
2017 - 2021
2017 - 2021Research Assistant PhD
Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology
2011 - 2017
2011 - 2017Research Assistant
Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology
Managerial Experience
2021 - Present
2021 - PresentInternship Committee Member
Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology
2025 - 2028
2025 - 2028Faculty Board Member
Istanbul University, Faculty of Pharmacy , Department of Pharmaceutical Technology
Non Academic Experience
2010 - 2010
2010 - 2010Uzman
Business Establishment Private, Pharmavision İlaç, Uzman
2010 - 2010
2010 - 2010Ruhsatlandırma Uzmanı
Pharmavision İlaç, Ruhsatlandırma Uzmanı
2003 - 2010
2003 - 2010Uzman
Business Establishment Private, Sanovel İlaç San. Tic Aş, Uzman
2003 - 2009
2003 - 2009Ar-Ge Uzmanı
Sanovel İlaç San. ve Tic A.Ş., Ar-Ge Uzmanı
Courses
Articles
All (34)
SCI-E, SSCI, AHCI (11)
SCI-E, SSCI, AHCI, ESCI (20)
ESCI (9)
Scopus (26)
TRDizin (9)
Other Publications (5)
2025
20251. Comprehensive Analytical Studies on the Solubility and Dissolution Rate Enhancement of Tadalafil with Type IV Lipid Formulations
Husuzade G., Demiralp B., Nazlı H., Boran T., Güngör S.
Pharmaceutics , vol.17, no.11, pp.1-18, 2025 (Peer-Reviewed Journal)
2025
20252. A Review of Formulation Strategies for Cyclodextrin-Enhanced Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs)
Alloush T., DEMİRALP B.
International Journal of Molecular Sciences
, vol.26, no.13, 2025 (SCI-Expanded)
2025
20253. Exploring the promise of lipoplexes: From concept to clinical applications
Al-Shihabi A. M., Al-Mohaya M., Haider M., DEMİRALP B.
International Journal of Pharmaceutics
, vol.674, 2025 (SCI-Expanded)
2024
20244. Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies
MESUT B., Al-Mohaya M., Gholap A. D., YEŞİLKAYA E., Das U., Akhtar M. S., et al.
Naunyn-Schmiedeberg's Archives of Pharmacology
, vol.397, no.12, pp.9243-9279, 2024 (SCI-Expanded)
2024
20245. In silico approaches which are used in pharmacy
Al-Mohaya M., MESUT B., Kurt A., ÇELİK Y. S.
Journal of Applied Pharmaceutical Science
, vol.14, no.4, pp.225-239, 2024 (Scopus)
2024
20246. An Overview of Wearable Medical Device Applications
ÇELİK Y. S., İlçe E., MESUT B., Özsoy Y.
Journal of Research in Pharmacy
, vol.28, no.3, pp.722-732, 2024 (ESCI)
2023
20237. Artificial intelligence evaluation of release properties of tablet formulation containing flurbiprofen
Mesut B., Çelik Y. S.
Journal of Advanced Research in Health Sciences , vol.6, no.3, pp.332-336, 2023 (Peer-Reviewed Journal)
2023
20238. Systematic Screening Study for the Selection of Proper Stabilizers to Produce Physically Stable Canagliflozin Nanosuspension by Wet Milling Method
Pirincci Tok Y., MESUT B., GÜNGÖR S., Sarıkaya A. O., Aldeniz E. E., Dude U., et al.
Bioengineering
, vol.10, no.8, 2023 (SCI-Expanded)
2023
20239. A Novel Semi-Solid Self-Emulsifying Formulation of Aprepitant for Oral Delivery: An In Vitro Evaluation
Nazlı H., MESUT B., AKBAL DAĞISTAN Ö., Özsoy Y.
Pharmaceutics
, vol.15, no.5, 2023 (SCI-Expanded)
2023
202310. Excipients for Orally Disintegrating Tablets: Compaction Data Analysis and Study of Tableting Properties of Lubricated Co-processed Excipients
Onayo M. M., Özalp Y., Jiwa N., MESUT B., GÜNGÖR S.
Latin American Journal of Pharmacy
, vol.42, no.8, pp.1655-1665, 2023 (SCI-Expanded)
2023
202311. Nasal in situ gels as a drug delivery system: An overview of literature and clinical studies
ÇELİK Y. S., Örenli B., Al-Mohaya M., MESUT B., Özsoy Y.
Journal of Research in Pharmacy
, vol.27, no.5, pp.1875-1888, 2023 (ESCI)
2021
202112. Estimating the Optimal Dexketoprofen Pharmaceutical Formulation with Machine Learning Methods and Statistical Approaches
Baskor A., Tok Y. P., Mesut B., Ozsoy Y., Ucar T.
HEALTHCARE INFORMATICS RESEARCH
, vol.27, no.4, pp.279-286, 2021 (ESCI)
2021
202113. Examining the basic principles of quality by design (QbD) approach in analytical studies
MESUT B., Onal C., Aksu B., ERGİNER Y.
ISTANBUL JOURNAL OF PHARMACY
, vol.51, no.2, pp.271-276, 2021 (ESCI)
2021
202114. A Review On Current Perspective Of Gastroretentive Drug Delivery Systems Prioritising Floating Dosage Forms
Başarır N. S., Mesut B., Erginer Y.
Sağlık Bilimlerinde İleri Araştırmalar Dergisi , vol.4, no.2, pp.43-64, 2021 (Peer-Reviewed Journal)
2021
202115. Çözünürlüğü Düşük Olan Etken Maddeler İçin Farmasötik Yaklaşımlar ve Aprepitantın Çözünürlüğü
Erginer Y., Nazlı H., Mesut B.
FABAD J. Pharm. Sci. , vol.46, no.3, pp.325-344, 2021 (Peer-Reviewed Journal)
2021
202116. Preparation and in vitro studies of fixed-dose tablet combination of repaglinide and metformin
Sahin S., MESUT B., Durgun M. E., Ozcelik E., ERGİNER Y.
ISTANBUL JOURNAL OF PHARMACY
, vol.51, no.1, pp.26-34, 2021 (ESCI)
2021
202117. Formulation development and evaluation of taste-masked atomoxetine hydrochloride orally disintegrating tablets (Odts)
Kazaz Ç., Mesut B., Özsoy Y., Ocak E. M.
Journal of Research in Pharmacy
, vol.25, no.5, pp.715-727, 2021 (ESCI)
2021
202118. Stability indicating method development and validation of ranolazine extended release tablets
Durak E. A., Kurtgöz İ., MESUT B., CEVHER E., Özsoy Y.
Acta Pharmaceutica Sciencia
, vol.59, no.3, pp.419-434, 2021 (Scopus)
2020
202019. A Solid Ultra Fine Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) of Deferasirox for Improved Solubility: Optimization, Characterization, and In Vitro Cytotoxicity Studies
Alghananim A., Özalp Y., Mesut B., Serakinci N., Özsoy Y., Güngör S.
PHARMACEUTICALS
, vol.13, no.8, 2020 (SCI-Expanded)
2020
202020. The effect of the systemic folic acid intake as an adjunct to scaling and root planing on clinical parameters and homocysteine and C-reactive protein levels in gingival crevicular fluid of periodontitis patients: A randomized placebo-controlled clinical trial
Keçeli H. G., Ercan N., Karsiyaka Hendek M., Kisa U., Mesut B., Olgun E.
Journal of Clinical Periodontology
, vol.47, pp.602-613, 2020 (SCI-Expanded)
2019
201921. Product transfer from lab-scale to pilot-scale of quetiapine fumarate orodispersible films using quality by design approach
Bulbul E. O., Mesut B., Cevher E., Oztas E., Ozsoy Y.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
, vol.54, 2019 (SCI-Expanded)
2019
201922. Ağızda Dağılan Tabletlerde Formülasyon Tasarımı ve Tat Değerlendirmesi
KAZAZ Ç., OCAK M., MESUT B., ÖZSOY Y.
FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , vol.44, no.2, pp.169-178, 2019 (Scopus)
2019
201923. Developing Alfuzosin Tablet Formulation Based on Quality by Design (QbD) Approach by Using Artificial Neural Network
Aksu N. B., Mesut B., Erginer Y.
LATIN AMERICAN JOURNAL OF PHARMACY
, vol.38, pp.668-676, 2019 (SCI-Expanded)
2019
201924. Formulation design and taste assessment in orally disintegrating tablets Ağızda dağılan tabletlerde formülasyon tasarımı ve tat değerlendirilmesi
KAZAZ Ç., Ocak M., MESUT B., Özsoy Y.
Fabad Journal of Pharmaceutical Sciences
, vol.44, no.2, pp.169-178, 2019 (Scopus)
2017
201725. Quetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks
Ozcelik E., Mesut B., Aksu B., Ozsoy Y.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES
, vol.14, no.3, pp.213-221, 2017 (ESCI)
2017
201726. BUDESONIDE SELF-NANOEMULSION FORMULATION AS AN ORAL DRUG DELIVERY SYSTEM: PREPARATION, CHARACTERIZATION AND CYTOTOXICITY STUDIES
Mesut B., Tekarslan Şahin Ş. H., Erginer Y.
PressAcademia Procedia , vol.5, no.1, pp.41-46, 2017 (Peer-Reviewed Journal)
2017
201727. Applications of cell culture studies in pharmaceutical technology
Tekarslan Şahin Ş. H., MESUT B., Özsoy Y.
Acta Pharmaceutica Sciencia
, vol.55, no.3, pp.63-79, 2017 (Scopus)
2017
201728. Formulation design of the oral disintegrating tablets including alfuzosin hydrochloride with risk evaluation via quality by design
Güncan G., Yeğen G., Mesut B., Aksu B., Özsoy Y.
Acta Pharmaceutica Sciencia
, vol.55, pp.57-76, 2017 (Scopus)
2016
201629. In vitro skin permeation of escin in the new gel formulation of Aesculus hippocastanum (Horse Chestnut)
Ozkan E., Mesut B., Polat A., Tan N.
ISTANBUL JOURNAL OF PHARMACY
, vol.46, no.2, pp.79-88, 2016 (ESCI)
2015
201530. Ksantan Zamkının Uzatılmış Salımlı Tabletlerde Kullanımı
Özçelik E., MESUT B., ERGİNER Y.
Türkiye Klinikleri Eczacılık Bilimleri Dergisi , vol.4, no.2, pp.79-88, 2015 (Peer-Reviewed Journal)
2015
201531. The Place of Drug Product Critical Quality Parameters in Quality by Design
Mesut B., Aksu B., Erginer Y.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.12, pp.75-92, 2015 (Scopus)
2015
201532. The Place of Drug Product Critical Quality Parameters in Quality by Design (QBD)
MESUT B., ÖZSOY Y., AKSU N. B.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES
, vol.12, no.1, pp.75-92, 2015 (Scopus)
2015
201533. Quality by design (QbD) for pharmaceutical area
Aksu B., Mesut B.
ISTANBUL JOURNAL OF PHARMACY
, vol.45, no.2, pp.233-251, 2015 (ESCI)
2013
201334. Design of Sustained Release Tablet Formulations of Alfuzosin HCl by means of Neuro-Fuzzy Logic
Mesut B., Aksu N. B., Ozsoy Y.
LATIN AMERICAN JOURNAL OF PHARMACY
, vol.32, pp.1288-1297, 2013 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2023
20231. Systematic And Predictive Screening Study For Selection Of Proper Stabilizer Agents For Fabrication Of Physically Stable Drug Nanosuspension
PİRİNÇCİ TOK Y., MESUT B., ÖZSOY Y.
4. International Marmara Scientific Research and Innovation Congress, Turkey, 11 - 12 March 2023, (Summary Text)
2023
20232. SYSTEMATIC AND SEMIPREDICTIVE SCREENING STUDY OF STABILIZER AGENTS FOR FABRICATION OF PHYSICALLY STABLE DRUG NANOSUSPENSION
Pirincci Tok Y., Mesut B., Erginer Y.
4. INTERNATIONAL MARMARA SCIENTIFIC RESEARCH AND INNOVATION CONGRESS, İstanbul, Turkey, 11 - 12 March 2023, pp.37-38, (Summary Text)
2021
20213. In vitro characterization of micelles based drug delivery systems for ocular fungal infections
Durgun M. E., Mesut B., Güngör S., Erginer Y.
CRS Virtual Annual Meeting 2021, 25 - 29 July 2021, (Unpublished)
2021
20214. Development of the Micellar Based Ocular In Situ Gelling Systems of Posaconazole with Quality by Design (QbD) Approach
Durgun M. E., Mesut B., Güngör S., Erginer Y.
13th International Symposium on Pharmaceutical Sciences (ISOPS), 22 - 25 June 2021, pp.41-42, (Full Text)
2021
20215. Machine Learning Models and Statistical Dexketoprofen Pharmaceutical Dosage of Approaches Application In The Form
Başkor A., Pirinçci Tok Y., Mesut B., Erginer Y., Uçar T.
4th International Conference on Data Science and Applications (ICONDATA’21), Muğla, Turkey, 4 - 06 June 2021, pp.14, (Summary Text)
2021
20216. Optimization Studies of Alfuzosin Tablet Formulation Using Machine Learning Models
Başkor A., Mesut B., Aksu N. B., Erginer Y.
4th International Conference on Data Science and Applications (ICONDATA'21), Muğla, Turkey, 4 - 05 June 2021, pp.32, (Summary Text)
2020
20207. BCS II Sınıf Olanzapin’in Çözünürlüğünün Kendiliğinden Nanoemülsifiye Olabilen Sistemler ile Arttırılması
ABDULLAYEV R., MESUT B., OCAK M.
V. Uluslararası Battalgazi Bilimsel Çalışmalar Kongresi, 18 - 20 December 2020, (Summary Text)
2020
20208. BCS Sınıf II Olanzapin'in Çözünürlüğünün Kendiliğinden Nanoemülsifiye Olabilen Sistemlerle Arttırılması
Abdulayeva R., Mesut B., Ocak E. M.
International Battalgazi Scientific Studies Congress-V, Malatya, Turkey, 18 - 20 December 2020, pp.1, (Summary Text)
2020
20209. Development of a Solid-Type IV Self-Emulsifying Drug Delivery System of BCS Class II Drug
HUSUZADE G., MESUT B., GÜNGÖR S.
1st International Electronic Conference on Pharmaceutics, 1 - 15 December 2020, (Summary Text)
2020
202010. Development of a Solid Self-Emulsifying Drug Delivery System of a Weakly Basic BCS Class II Drug
Husuzade G., Mesut B., Güngör S.
The 1st International Electronic Conference on Pharmaceutics , 1 - 15 December 2020, pp.1, (Summary Text)
2020
202011. Design, Preparation and Evaluation of Taste-Masked Dexketoprofen of Orally Disintegrating Tablet By Using QbD Approach
Pirinçci Tok Y., Mesut B., Erginer Y.
The 1st International Electronic Conference on Pharmaceutics, Basel, Switzerland, 1 - 03 December 2020, pp.1, (Summary Text)
2019
201912. Risk Assesment of Taste Masked Orally Disintegrating Tablets of Dexketoprofen
Pirinçci Tok Y., Mesut B., Erginer Y., Yetilmezsoy K.
7th International BAU Drug Design Congress, İstanbul, Turkey, 19 - 21 December 2019, pp.164, (Full Text)
2019
201913. Risk Assessment of Taste Masked Orally Disintegrating Tablets of Dexketoprofen
PİRİNÇCİ Y., MESUT B., ÖZSOY Y., YETİLMEZSOY K.
7th International BAU Drug Design Congress, 19 - 21 December 2019, (Summary Text)
2019
201914. Designing an Orally Disintegrated Film Formulation Containing Ondansetron In Quality By Design Perspective
Demirkol F., Mesut B., Kalayı M., Aksu B.
7th International BAU Drug Design Congress , İstanbul, Turkey, 19 - 21 December 2019, pp.208, (Summary Text)
2019
201915. Development of Melatonin-Containing Orally Disintegrated Tablets Using Artificial Intelligensys Methodology
Mesut B., Alkan B., Pirinçci Tok Y., Erginer Y., Yetilmezsoy K.
8th BBBB International Conference on Pharmaceutical Science, İzmir, Turkey, 14 - 16 October 2019, pp.72-73, (Full Text)
2019
201916. Self Nanoemulsifying Drug Delivery System Formulation Design of Aprepitant
Nazlı H., Mesut B., Erginer Y.
8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.138-139, (Full Text)
2019
201917. Development of Melatonin-Containing Orally Disintegrated Tablets Using Artificial Intelligence Methodology
MESUT B., ALKAN B., PİRİNÇCİ Y., ÖZSOY Y., YETİLMEZSOY K.
8th BBBB International Conference on Pharmaceutical Sciences, 14 - 16 October 2019, (Full Text)
2019
201918. Development of Aripiprazole Orally Disintegrating Film Formulation By Using Quality by Design Approach
Mesut B., Kalayı M., Aksu B., Erginer Y.
8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 14 - 16 October 2019, pp.312-313, (Full Text)
2019
201919. Preformulation Studies of Self Nanoemulsifying Drug Delivery System (SNEDDS) Formulation of Deferasirox
Alghananim A., Özalp Y., Mesut B., Güngör S., Erginer Y.
8th BBBB International Conference on Pharmaceutical Sciences , İzmir, Turkey, 14 - 16 October 2019, pp.285-286, (Full Text)
2019
201920. Developing Ondansetron Orally Disintegrated Film Formulation Under Risk Assesment Perspective
Demirkol F., Mesut B., Kalayı M., Aksu B.
FIP World Congress, Abu Dhabi, United Arab Emirates, 22 - 26 September 2019, pp.1, (Summary Text)
2019
201921. Benefits of Computer-Based Systems In Quality Design
YEĞEN G., AKSU N. B., MESUT B.
International Conference on Data Science, Machine Learning and Statistics, 26 - 29 June 2019, (Summary Text)
2019
201922. Benefits of Computer-Based In Quality Design
Aksu B., Yeğen G., Mesut B.
International Conference On Data Science, Machine Learning and Statistics, Van, Turkey, 26 - 29 June 2019, pp.31, (Summary Text)
2018
201823. The Application of Artificial Neural Networks for the Development of Topical Flurbiprofen Microemulsion
Mesut B., Gürbüz A., Erdal M. S., Aksu B., Erginer Y., Güngör S.
12th Central European Symposium on Pharmaceutical Technology and Regulatory Affairs, Szeged, Hungary, 20 - 22 September 2018, pp.107-108, (Full Text)
2018
201824. The Application Of Artificial Neural Networks For The Development Of Topical Flurbiprofen Microemulsions
MESUT B., ERDAL M. S., AKSU N. B., ERGİNER Y., GÜNGÖR S.
12th CESPT, 20 - 22 September 2018, (Summary Text)
2018
201825. Development And Optimization Of Orodispersible Films Containing Quetiapine Fumarate
BÜLBÜL E. Ö., MESUT B., ÖZSOY Y.
19th International Pharmaceutical Techonology Symposium, 17 - 19 September 2018, (Summary Text)
2018
201826. Development and Optimization of Orodispesible Films Containing Quetiapine Fumarate
Özcan E., MESUT B., ERGİNER Y.
International Pharmaceutical Technology Symposium, Antalya, Turkey, 17 - 19 September 2018, pp.13, (Full Text)
2018
201827. Self Nanoemulsifying Drug Delivery System (SNEDDS) Formulation Design of Aprepitant
Nazlı H., MESUT B., tekarslan h., ERGİNER Y.
International Pharmaceutical Technology Symposium, Antalya, Turkey, 17 - 19 September 2018, pp.12, (Full Text)
2017
201728. QBD Based Developement and Characterisation of Microemulsion Formulations for Improved Skin Delivery of Flurbiprofen
GÜRBÜZ A., MESUT B., ERDAL M. S., AKSU N. B., GÜNGÖR S.
2nd International GPSS Gazi Pharma Symposium Series, 11 - 13 October 2017, (Summary Text)
2017
201729. Evaluation of cytotoxicity of of budesonide-loaded Snedds on human colon cancer cell lines
MESUT B., TEKARSLAN ŞAHİN Ş. H., ERGİNER Y.
2nd International Gazi Pharma Symposium Series, İstanbul, Turkey, 11 - 13 October 2017, pp.96, (Full Text)
2017
201730. QBD-Based Development and Characterisation of Microemulsion Formulations for Improved Skin Delivery of Flurbiprofen
GÜRBÜZ A., MESUT B., ERDAL M. S., Aksu B., ERGİNER Y., GÜNGÖR S.
2nd International Gazi Pharma Symposium Series, Ankara, Turkey, 11 - 13 October 2017, pp.36, (Full Text)
2017
201731. Design of extended release tablet formulation using artificial neutral network programs
ÖZÇELİK E., MESUT B., AKSU N. B., ERGİNER Y.
CRS Annual Meeting 2017, 16 - 19 July 2017, (Summary Text)
2017
201732. Design of Extended Release Tablet Formulation Using Artificial Neural Network
Özçelik E., Mesut B., Aksu B., Erginer Y.
CRS Annual Meeting & Exposition, Massachusetts, United States Of America, 16 - 19 July 2017, pp.1, (Summary Text)
2017
201733. Budesonide Self-microemulsion Formulation as a oral Drug Delivery System
Mesut B., Erginer Y.
6th Pharmaceutical Sciences World Congress 2017, Stockholm, Sweden, 21 - 24 May 2017, pp.1, (Summary Text)
2017
201734. Budesonide self-nanoemulsion formulation as an oral drug delivery system: Preparation,characterization and cytotoxicity studies
Mesut B., Tekarslan Şahin Ş. H., Erginer Y.
2nd World Conference on Technology, Innovation and Entrepreneurship, İstanbul, Turkey, 12 - 14 May 2017, pp.54, (Summary Text)
2017
201735. Artificial Neural Networks in Pharmaceutical Technology
MESUT B., TEKARSLAN ŞAHİN Ş. H., ERGİNER Y.
2nd World Conference on Technology, Innovation and Entrepreneurship, İstanbul, Turkey, 12 - 14 May 2017, (Full Text)
2017
201736. Implementing of Quality By Design Approach Using Different Computerized Systems
Mesut B., Aksu B., Erginer Y.
2nd European Conference on Pharmaceutics, Krakow, Poland, 3 - 04 April 2017, pp.1, (Full Text)
2016
201637. The Importance of the Self Nano/Microemulsifying Drug Delivery Systems (SN/MEDDs) for Oral Drug Delivery
MESUT B., TEKARSLAN ŞAHİN Ş. H., ERGİNER Y.
4th BAU DRUG DESIGN Congress, İstanbul, Turkey, 13 - 15 October 2016, (Full Text)
2016
201638. Optimization of Flurbiprofen microemulsions Using Artificial neural networks
MESUT B., GÜRBÜZ A., Aksu B., ERDAL M. S., GÜNGÖR S.
4th Congress on Innovation in Drug Delivery Site-Specific Drug Delivery, Antibes-Juan Les Pins, France, 25 - 28 September 2016, pp.74, (Full Text)
2016
201639. Colloidal Nanocariers of flurbiprofen Physicochemical Characterisation and in vitro Skin Permeation Studies
GÜRBÜZ A., MESUT B., ERDAL M. S., GÜNGÖR S.
18 th International Pharmaceutical Technology symposium, 18 - 21 September 2016, (Summary Text)
2016
201640. Design and Optimization of Self-Nanoemulsifying Drug Delivery systems (SNEDDs) Containing Budesonide
MESUT B., ERGİNER Y.
International Pharmaceutical Technology Symposium, Antalya, Turkey, 18 - 21 September 2016, pp.172-174, (Full Text)
2016
201641. Colloidal Nanocarriers of Flurbiprofen: Physicochemical Characterization and In Vitro Skin Permeation Studies
GÜRBÜZ A., MESUT B., ERDAL M. S., GÜNGÖR S.
International Pharmaceutical Technology Symposium, Antalya, Turkey, 18 - 21 September 2016, pp.194-196, (Full Text)
2016
201642. SNEEDs formulation of Budesonide to improve its solubility Optimization and in vitro release studies
ERGİNER Y., MESUT B.
Drug Formulation &Bioavailability Congress, 5 - 07 September 2016, (Summary Text)
2017
201743. SNEDDs Formulation of Budesonide to İmprove its Solubility: Optimization and in vitro release studies
Erginer Y., Mesut B.
Drug Formulation & Bioavailability Congress, Beijing, China, 5 - 07 September 2017, pp.51, (Summary Text)
2015
201544. Quetiapine Fumarate Sustained Release Tablet Formulation Design By Using Inform V.4 ANN Program
Özçelik E., Mesut B., Aksu B., Erginer Y.
11th International Symposium on Pharmaceutical Sciences, Ankara, Turkey, 9 - 12 June 2015, pp.129, (Full Text)
2014
201445. VEHICLE COMPOSITION EFFECTS ON IN VITRO TRANSSCLERAL IONTOPHORETIC TRANSPORT OF MOXIFLOXACIN
MESUT B., ERGİNER Y., GÜNGÖR S.
17th International Pharmaceutical Technology Symposium, Antalya, Turkey, 8 - 10 September 2014, pp.294-296, (Full Text)
2014
201446. Optimization Studies of Quetiapine Fumarate Modified Release Tablets By Using Artificial Neural Network Programs
Özçelik E., Mesut B., Aksu B., Erginer Y.
9th World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology, Lisbon, Portugal, 31 March - 03 April 2014, pp.1-2, (Full Text)
2013
201347. Quetiapine Fumarate Modified Release Tablet Formulations Optimization Based on Genetic Algorithm Program
Özçelik E., Mesut B., Aksu B., Erginer Y.
International Multidisciplinary Symposium on Drug Research & Development, Antalya, Turkey, 28 - 30 November 2013, pp.1, (Summary Text)
2013
201348. Quetiapine fumarate sustained release tablet formulations design by using artificial neural network
Özçelik E., Mesut B., Aksu B., Erginer Y.
EuPat 6 European QbD&PAT Conference , Porto, Portugal, 23 - 24 September 2013, pp.40-41, (Summary Text)
2012
201249. Optimization of Alfuzosin Tablet Formulations By Using Genetic Algorithm Program
Mesut B., Aksu B., Erginer Y.
EuPat 5 European QbD&PAT Conference, Ghent, Belgium, 9 - 10 May 2012, pp.33, (Summary Text)
2011
201150. Optimization of Alfuzosin HCl Tablet Formulations Using Artificial Neural Network
Mesut B., Aksu B., Erginer Y.
4th BBBB Bled- International Conference on Pharmaceutical Sciences, Ljubljana, Slovenia, 29 September - 01 November 2011, pp.94-95, (Full Text)
2011
201151. Optimization of Alfuzosin HCl Modified Release Tablet Formulations Using Artificial Neural Network
Aksu B., Mesut B., Erginer Y.
5th International Congress on Pharmaceutical Engineering, Graz, Austria, 29 - 30 September 2011, pp.81, (Summary Text)
2011
201152. Optimization of Alfuzosin Sustained Release Tablet Formulations Using Artificial Neural Network
Mesut B., Aksu B., Erginer Y.
18 th International Syposium on Microencapsulation, Antalya, Turkey, 12 - 14 September 2011, pp.216-219, (Full Text)
Books
2025
20251. Self nanoemulsifying drug delivery systems in colon targeting
Demiralp B., Al-Mohaya M., Çelik Y. S., Güngör S., Erginer Y.
in: Nanocarriers Based Colon Targeting, Lalit Kumar,Yashwant V. Pathak, Editor, Elsevier Science, Oxford/Amsterdam , Massachusetts, pp.689-716, 2025
2025
20252. Evaluation of lipid-based formulation for pulmonary delivery
Al-Mohaya M., Çelik Y. S., Demiralp B.
in: Lipids in Pulmonary Drug Delivery, Md Faiyazuddin,Hasan Ali,Md Akbar,Babar Iqbal, Editor, Elsevier Science, Oxford/Amsterdam , Massachusetts, pp.337-352, 2025
2024
20243. Quality By Design Approach for Novel Drug Delivery Systems
Al-Mohaya M., MESUT B.
in: Introduction to Quality by Design (QbD) From Theory to Practice, , Editor, Springer Nature Singapore, pp.243-261, 2024
2024
20244. TARGETING STRATEGIES WITH NEW DRUG DELIVERY SYSTEMS IN CANCER THERAPY
ÇELİK Y. S., DEMİRALP B., ERGİNER Y.
in: CANCER: FROM GENOMICS TO PHARMACEUTICS, KARAKAŞ ZEYNEP, ERDAL MERYEM SEDEF, SAYİTOĞLU MÜGE, SOLUK TEKKEŞİN MERVA, Editor, Istanbul University, pp.240-262, 2024
2023
20235. Role of artificial intelligence in quality profiling and optimization of drug products
MESUT B., BAŞKOR A., AKSU N. B.
in: A Handbook of Artificial Intelligence in Drug Delivery, Anil Philip, Aliasgar Shahiwala, Mamoon Rashid, Md Faiyazuddin, Editor, Elsevier Academic Press, pp.35-54, 2023
2022
20226. Lipid Based Formulations
Al-Mohaya M., Mesut B.
in: SAĞLIKTA GÜNCEL GELİŞMELER IŞIĞINDA TEMEL ve KLİNİK YAKLAŞIMLAR-II, Özge Gülmez,Buruç Erkan,Emir Kaan İzci, Editor, Ekin Yayınevi, Bursa, pp.133-162, 2022
Funded Projects
2025 - Present
2025 - PresentSNEDDS Tablet Formülasyonlarının 3D Baskı Tekniği ile Hazırlanması ve Tablet Şeklinin Çözünme Hızı Üzerine Etkisinin Değerlendirilmesi
Project Supported by Higher Education Institutions , BAP PhD
DEMİRALP B. (Executive), ÇELİK Y. S.
2022 - Present
2022 - PresentKompleks Jenerik İlaçların Eşdeğerliğinin Kanıtlanmasına Yönelik In vitro Yöntemlerin Geliştirilmesi ve Fizyolojik Temelli Farmakokinetik Modelleme ile In vivo In vitro Korelasyonun Değerlendirilmesi
Project Supported by Higher Education Institutions , BAP Other
GÜNGÖR S. (Executive), ERGİNER Y., AYDİLEK N., FOTAKİ N., MESUT B.
2023 - 2025
2023 - 2025
Tasarım ile Kalite Yaklaşımı Çerçevesinde 3B Baskı Tekniği Kullanılarak Çok Katmanlı Tablet Formülasyonunun Hazırlanması, In Vitro ve In Siliko Çalışmaları
Research Project of the Presidency of Turkey Health Institutes (TÜSEB)
(Project Abstract)
Mesut B. (Executive), Erginer Y., Awad A.
2023 - 2024
2023 - 2024
İmmünomodülatör ve Antiviral Etkili Etkili Fitofarmasötiklerin Geliştirilmesi
EU Supported Other Project
MESUT B. (Executive)
2023 - 2024
2023 - 2024Ağızda Dağılan C Vitamini Tablet Formülasyonlarının Yapay Sinir Ağıları ile Optimizasyonu
TUBITAK Project , 2209-A - Üniversite Öğrencileri Araştırma Projeleri Destekleme Programı
(Project Abstract)
Mesut B., Ulu H.(Executive), Gezgin A.
2021 - 2024
2021 - 2024Oküler Uygulamaya Yönelik Antifungal Etken Madde Yüklü Polimerik Miseller ile Nanolif Sistemlerinin Geliştirilmesi Formülasyonun QbD ile Optimizasyonu Karakterizasyonu İn vitro Ex vivo ve İn vivo Çalışmalar ile Değerlendirilmesi
Project Supported by Higher Education Institutions , BAP Research Project
GÜNGÖR S. (Executive), HACIOĞLU M., ELBAY A., KIRIK F., YILDIZ PEKÖZ A., MESUT B., et al.
2023 - 2023
2023 - 2023Ready to Use Yardımcı Maddelerin Toz Özelliklerinin ve Tablet Özelliklerinin İncelenmesi
Project Supported by Higher Education Institutions , BAP MSc
DEMİRALP B. (Executive), Kakah M.
2022 - 2023
2022 - 2023AĞIZ İÇİ YARALARDA ANTİMİKROBİYAL AMAÇLI KULLANILMAK ÜZERE PUNİCA GRANATUM BİTKİSİNİN KABUKLARINDAN ELDE EDİLEN EKSTRENİN İN SİTU JEL FORMÜLASYONUNUN GELİŞTİRİLMESİ
Project Supported by Higher Education Institutions , BAP Other
DEMİRALP B. (Executive), KORKUT B., YEŞİLKAYA E., TURAN A.
2020 - 2022
2020 - 2022Famotidin ve Esomeprazol Kombine Etken Maddeli Yüzebilen Dozaj Formlarının QbD ile Geliştirilmesi Yapay Zeka İle Optimizasyonu
Project Supported by Higher Education Institutions , BAP Research Project
Mesut B. (Executive), Başarır S. N., Durgun M. E., Erginer Y.
2019 - 2021
2019 - 2021Çözünürlüğü düşük etkin maddenin kendiliğinden emülsifiye olan yeni formülasyonlarının geliştirilmesi, in vitro ve in vivo olarak değerlendirilmesi
Project Supported by Higher Education Institutions , BAP Research Project
ERGİNER Y. (Executive), NAZLI H., ÖZTÜRK D., MESUT B., OKYAR A.
2018 - 2020
2018 - 2020
Yapay Zeka Teknolojisi Kullanarak Tasarım ile Kalite Yaklaşımı Çerçevesinde Melatonin İçeren Ağızda Dağılan Tablet ODT Formülasyonun Geliştirilmesi In vitro ve Sitotoksisite Analizleri
Project Supported by Higher Education Institutions , BAP Research Project
DEMİRALP B. (Executive), ERGİNER Y., YETİLMEZSOY K., TEKARSLAN ŞAHİN Ş. H.
2017 - 2019
2017 - 2019Aprepitant etkin maddesini içeren kendiliğinden emülsifiye olabilen sistemlerin SMEDD hazırlanması ve in vitro karakterizasyonunun değerlendirilmesi
Project Supported by Higher Education Institutions , BAP Research Project
ERGİNER Y. (Executive), MESUT B., TEKARSLAN Ş. H.
2014 - 2017
2014 - 2017Ölçek Büyütmeye Uygun Nanoemülsiyon Formülasyonunun QbD ile Tasarımı ve Yapay Sinir Ağları ile Optimizasyonu
Project Supported by Higher Education Institutions , BAP PhD
ERGİNER Y. (Executive), MESUT B.
2012 - 2014
2012 - 2014Başlangıç Periodontal tedaviye ek olarak folik asit kullanımının kronik periodontitisli bireylerdeki klinik parametrelere ve dişeti oluğu sıvısındaki homosistein ve c-reaktif protein seviyelerine etkisi
Project Supported by Higher Education Institutions , BAP Research Project
(Project Abstract)
Keçeli H. G.(Executive), Ercan N., Hendek M., Kısa Ü., Mesut B., Olgun Erdemir H. E.
Patent
2019
2019CANNABİDİOLÜN NAZAL UYGULANAN KOLLOİDAL FORMÜLASYONLARI
Patent
Pending / Applied, The Invention Recourse Number: 2019/22178 , Standard Registration
2018
2018Hint Yağı İçeren Kapsül Formunda Farmasötik Bileşim
Patent
Pending / Applied, The Invention Recourse Number: 2018/20564 , Standard Registration
2016
2016APREPİTANTIN KENDİLİĞİNDEN EMÜLSİFİYE OLAN SALIM SİSTEMİ İLE HAZIRLANMIŞ KATI DOZAJ FORMÜLASYONU
Patent
Pending / Applied, The Invention Recourse Number: , Standard Registration
2016
2016APREPİTANT VE DEKSAMETAZONUN KENDİLİĞİNDEN EMÜLSİFİYE OLAN SALIM SİSTEMİ İLE HAZIRLANMIŞ KATI DOZAJ FORMU KOMBİNASYONU
Patent
Pending / Applied, The Invention Recourse Number: , Standard Registration
2016
2016Aripiprazole Formulations
Patent
Registered / Approved, The Invention Registration Number: EP2359816B1
2016
2016Alfuzosin'in Uzatılmış Salımlı Tablet Formülasyonu
Patent
Registered / Approved, The Invention Registration Number: 2012 06229 , Standard Registration
2014
2014Aripiprazol Formülasyonları
Patent
Registered / Approved, The Invention Registration Number: TR 2010/00948 B , Standard Registration
2014
2014Extended Release Tablet Formulations of Quetiapine
Patent
Pending / Applied, The Invention Recourse Number:
2013
2013Ketiapin'in Uzatılmış Salımlı Tablet Formülasyonu
Patent
Pending / Applied, The Invention Recourse Number: , Standard Registration
Memberships and Roles in Scientific Organizations
2017 - Present
2017 - PresentAPGI
Member
2011 - Present
2011 - PresentKontrollü Salım Sistemleri Derneği (CRS)
Member
2013 - 2017
2013 - 2017ISPE
Member
Peer Reviews in Scientific Publications
August 2020
August 2020Istanbul Journal of Pharmacy
Journal Indexed in ESCI
August 2020
August 2020Istanbul Journal of Pharmacy
Journal Indexed in ESCI
January 2020
January 2020Turkish Journal Of Pharmaceutical Sciences
Journal Indexed in ESCI
October 2019
October 2019Journal Of Research In Pharmacy
Journal Indexed in ESCI
August 2019
August 2019Turkish Journal of Pharmaceutical Sciences
Journal Indexed in ESCI
July 2019
July 2019Turkish Journal of Pharmaceutical Sciences
Journal Indexed in ESCI
June 2019
June 2019Journal of Research In Pharmacy
Journal Indexed in ESCI
May 2019
May 2019INTERNATIONAL JOURNAL OF PHARMACEUTICS
Journal Indexed in SCI-E
March 2019
March 2019Journal of Research in Pharmacy
Journal Indexed in ESCI
March 2019
March 2019Journal of Research in Pharmacy
Journal Indexed in ESCI
December 2018
December 2018